medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2015, Number 6

<< Back Next >>

Rev Invest Clin 2015; 67 (6)

Randomized Phase II Study of Talc Versus Iodopovidone for the Prevention of Seroma Formation Following Modified Radical Mastectomy

Garza-Gangemi AM, Barquet-Muñoz SA, Villarreal-Colín SP, Medina-Franco H, Cortés-González R, Vilar-Compte D, Cantú-de-León D

Language: English
References: 37
Page: 357-365
PDF size: 102.07 Kb.


ABSTRACT

Background: The most common complication following modified radical mastectomy is seroma formation. Numerous approaches have been attempted to prevent this complication, ranging from the use of chemical substances to mechanical means, and none of these have proven to be consistently reliable. Aim: The aim of this study was to evaluate the safety and efficacy of talc in preventing postoperative seromas compared with iodine and standard care. Methods: Patients with breast cancer undergoing modified radical mastectomy were randomly assigned to one of three study groups: control, subcutaneous talc, or iodine application. The primary endpoint was frequency of seroma formation. Secondary outcomes included wound complications (surgical site infection, flap necrosis, and wound dehiscence), analgesic use, postoperative pain, total drain outputs, and drainage duration. Results: Of the 86 patients randomized in the study, 80 were analyzed. After interim analysis, the iodine intervention was discontinued because of increased adverse outcomes (drainage duration and total amount of fluid drained). Talc failed to demonstrate that its application in subcutaneous breast tissue prevents seroma formation (19.4% for talc group vs. 23.3% for control group; p = 0.70). However, patients who developed seroma in the talc group had fewer aspirations per patient seroma and less volume drained when compared with the control group (88.2 ± 73 vs. 158.3 ± 90.5; p = 0.17). Conclusions: Subcutaneous talc application was safe in the short term, but there was not sufficient evidence to support its use for seroma prevention following modified radical mastectomy in patients with breast cancer.


REFERENCES

  1. Jemal A, Bray F, Ferlay J. Global Cancer Statistics. CA Cancer J Clin. 2011;61:69-90.

  2. Ferlay J, Soerjomataram I, Dikshit R, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer- Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr, [Accessed on day/month/year].

  3. Van Bemmel JM, van de Velde CJH, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol. 2011; 37:829-35.

  4. Pogson C, Adwani A, Ebbs S. Seroma following breast cancer surgery. Eur J Surg Oncol. 2003;29:711-17.

  5. Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer. 2012;15:373-80.

  6. Okada N, Narita Y, Takada M, et al. Early removal of drains and the incidence of seroma after breast surgery. Breast Cancer. 2013;22:79-83.

  7. Ten Wolde B, van den Wildenberg FJ, Keemers-Gels ME, Polat F, Strobbe LJ. Quilting prevents seroma formation following breast cancer surgery: closing the dead space by quilting prevents seroma following axillary lymph node dissection and mastectomy. Ann Surg Oncol. 2014;21:802-7.

  8. CDC. Surgical Site Infection (SSI ) Event. 2015;1-27.

  9. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. Breast cancer in Mexico: a pressing priority. Reprod Health Matters. 2008;16:113-23.

  10. Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, et al. Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol. 2012;13:e335-e343.

  11. Xue DQ, Qian C, Yang L, Wang XF. Risk factors for surgical site infections after breast surgery: a systematic review and metaanalysis. Eur J Surg Oncol. 2012;38:375-81.

  12. Vilar-Compte D, Rosales S, Hernández-Mello N, Maafs E, Volkow P. Surveillance, control, and prevention of surgical site infections in breast cancer surgery: a 5-year experience. Am J Infect Control. 2009;37:674-9.

  13. Broadwater J, Edwards M, Kuglen C, Hortobagyi G, Ames F, Balch C. Mastectomy following preoperative chemotherapy. Ann Surg. 1990;213:126-9.

  14. Canavese G, Tomei D, Vecchio C. Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial. Eur J Surg Oncol. 1997;23:10-12.

  15. Furey PC, Macgillivray DC, Castiglione CL. Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer. J Surg Oncol. 1994;55:194-7.

  16. Davis GB, Peric M, Chan LS, Wong AK, Sener SF. Identifying risk factors for surgical site infections in mastectomy patients using the National Surgical Quality Improvement Program database. Am J Surg. 2013;205:194-9.

  17. Olsen MA, Chu-Ongsakul S, Brandt K, Dietz J, Mayfield J, Fraser V. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg. 2008;143:4-7.

  18. Agrawal A, Ayantunde AA, Cheung KL. Concepts of seroma formation and prevention in breast cancer surgery. ANZ J Surg. 2006;76:1088-95.

  19. Boostrom SY, Throckmorton AD, Boughey JC, et al. Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg. 2009;208:148-50.

  20. Khan S, Khan S, Chawla T, Murtaza G. Harmonic scalpel versus electrocautery dissection in modified radical mastectomy: a randomized controlled trial. Ann Surg Oncol. 2014;21:808-14.

  21. Yilmaz KB, Dogan L, Nalbant H, et al. Comparing scalpel, electrocautery and ultrasonic dissector effects: the impact on wound complications and pro-inflammatory cytokine levels in wound fluid from mastectomy patients. J Breast Cancer. 2011; 14:58-63.

  22. Sanguinetti A, Docimo G, Ragusa M, et al. Ultrasound scissors versus electrocautery in axillary dissection: our experience. G Chir. 2010;31:151-3.

  23. Garbay J-R, Thoury A, Moinon E, et al. Axillary padding without drainage after axillary lymphadenectomy- a prospective study of 299 patients with early breast cancer. Breast Care. 2012; 7:231-5.

  24. Sakkary M. The value of mastectomy flap fixation in reducing fluid drainage and seroma formation in breast cancer patients. World J Surg Oncol. 2012;10:8.

  25. Kottayasamy Seenivasagam R, Gupta V, Singh G. Prevention of seroma formation after axillary dissection- a comparative randomized clinical trial of three methods. Breast J. 2013;19:478-84.

  26. Almond LM, Khodaverdi L, Kumar B, Coveney EC. Flap anchoring following primary breast cancer surgery facilitates early hospital discharge and reduces costs. Breast Care (Basel). 2010;5:97-101.

  27. Light RW. New agents for pleurodesis. Curr Respir Care Rep. 2013;2:88-92.

  28. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Efficacy and safety of Iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir Med. 2006;100:2043-7.

  29. Agarwal R, Paul AS, Aggarwal AN, Gupta D, Jindal SK. A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis. Respirology. 2011; 16:1064-9.

  30. Throckmorton AD, Askegard-Giesmann J, Hoskin TL, et al. Sclerotherapy for the treatment of postmastectomy seroma. Am J Surg. 2008;196:541-4.

  31. Karcaaltincaba M, Akhan O. Radiologic imaging and percutaneous treatment of pelvic lymphocele. Eur J Radiol. 2005;55: 340-54.

  32. Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet. 2007;369:1535-9.

  33. Shaw PH, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004;CD002916.

  34. Xia H, Wang XJ, Zhou Q, Shi HZ, Tong ZH. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS One. 2014;9:e87060.

  35. Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer. 2006;54:1-9.

  36. Klima D, Belyansky I, Tsirline VB, et al. Application of subcutaneous talc after axillary dissection in a porcine model safely reduces drain duration and prevents seromas. J Am Coll Surg. 2012;214: 338-47.

  37. Klima D, Brintzenhoff R, Tsirline VB, et al. Application of subcutaneous talc in hernia repair and wide subcutaneous dissection dramatically reduces seroma formation and postoperative wound complications. Am Surg. 2011;77:888-94.




2020     |     www.medigraphic.com